drugset / Trial / NCT00481364

Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients

NCT00481364 ↗

Phase 3 Completed 446 enrolled Ercan OK Pfizer · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This prospective, randomized, controlled study aims to investigate the effects of atorvastatin treatment in hemodialysis patients concerning progression of coronary artery calcification, progression of carotid artery intima-media thickness, endothelial function, and inflammation.

Timeline

Start
2006-11
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg —